2017
DOI: 10.1016/j.nbd.2016.12.010
|View full text |Cite
|
Sign up to set email alerts
|

Combined chondroitinase and KLF7 expression reduce net retraction of sensory and CST axons from sites of spinal injury

Abstract: Axon regeneration in the central nervous system is limited both by inhibitory extracellular cues and by an intrinsically low capacity for axon growth in some CNS populations. Chondroitin sulfate proteoglycans (CSPGs) are well-studied inhibitors of axon growth in the CNS, and degradation of CSPGs by chondroitinase has been shown to improve the extension of injured axons. Alternatively, axon growth can be improved by targeting the neuron-intrinsic growth capacity through forced expression of regeneration-associa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
34
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 33 publications
(38 citation statements)
references
References 73 publications
4
34
0
Order By: Relevance
“…2C,D). These data indicate that when confronted with a deeper and more severe injury, KLF6stimulated axons are largely unable to regenerate, a finding reminiscent of prior findings with closely related KLF7 (21,23). Thus, although KLF-based manipulations elevate intrinsic regenerative ability in CST axons (22), extrinsic barriers continue to constrain growth.…”
Section: Resultssupporting
confidence: 63%
See 1 more Smart Citation
“…2C,D). These data indicate that when confronted with a deeper and more severe injury, KLF6stimulated axons are largely unable to regenerate, a finding reminiscent of prior findings with closely related KLF7 (21,23). Thus, although KLF-based manipulations elevate intrinsic regenerative ability in CST axons (22), extrinsic barriers continue to constrain growth.…”
Section: Resultssupporting
confidence: 63%
“…A transcription factor called KLF6 has emerged as a particularly potent promoter of CST axon growth by activating a set of complementary gene networks involved in axon extension (22). Yet these neuron-intrinsic interventions only partially restore growth ability, and stimulated axons generally circumvent partial injuries, but fail to traverse complete injuries, suggesting persistent environmental inhibition (23). To address extrinsic inhibition, an important advance has been the demonstration that grafts of neural progenitor cells (NPCs) placed into sites of spinal injury can attract regenerative ingrowth from CST axons (10).…”
Section: Introductionmentioning
confidence: 99%
“…For example, knockout of growth-inhibitory KLF4 promotes axon regeneration by retinal ganglion cells in the injured optic nerve (Moore et al, 2009; Qin et al, 2013). In contrast, forced expression of pro-regenerative KLF7 constructs improves axon regeneration by injured corticospinal tract (CST) neurons, and reduces dieback of axotomized sensory neurons (Blackmore et al, 2012; Wang et al, 2017). Importantly, exogenous KLF7 is poorly expressed in neurons, likely due to rapid protein degradation from an N-terminal targeting domain (Blackmore et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…Neuroprotective agents (e.g., methylprednisolone, gacyclidine, thyrotropin releasing hormone, nimodipine, etc.) against secondary SCI, together with neuroregenerative agents (e.g., gangliosides, Rho antagonist, anti-Nogo antibodies, acidic fibroblast growth factor) have been used in SCI (Table I) with mixed outcomes (2839). Recent studies also evaluated the potential beneficial effects of estrogen, which could be a neuroprotective agent in the treatment of SCI and TBI (4043).…”
Section: Introductionmentioning
confidence: 99%